Patient Preference for Everolimus in Combination With Exemestane or Capecitabine in Combination With Bevacizumab

Clinical trial NCT02248571 · COMPLETED

Trial details

NCT number: NCT02248571
Sponsor: iOMEDICO AG
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Breast Cancer Recurrent HER2/Neu-negative Carcinoma of Breast Hormone Receptor Positive Malignant Neoplasm of Breast

Start date: 2014-08-01
Primary completion: 2017-08-31
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.